Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of MEDI4893 in healthy adult subjects; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• MEDI4893

Snippet

Sponsor: MedImmune LLC | Conditions: Staphylococcus Aureus | Phase 1 | Status: COMPLETED